Skip to Content
Merck
All Photos(1)

Key Documents

816653

TSKgel® OApak-A (7 µm) HPLC Columns

L x I.D. 30 cm × 7.8 mm, carboxylic acid phase

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
41115711

product name

TSKgel® OApak-A HPLC Column, phase carboxylic acid, L × I.D. 30 cm × 7.8 mm, 7 μm particle size

material

stainless steel

product line

TSKgel®

feature

counter ion H+

manufacturer/tradename

Tosoh 16653

parameter

≤20% organic solvent
0.8 mL/min flow rate
10-60 °C temperature
70 bar max. pressure

technique(s)

HPLC: suitable

L × I.D.

30 cm × 7.8 mm

matrix

hydroxylated methacrylic polymer

matrix active group

carboxylic acid phase

particle size

7 μm

operating pH

2-12

separation technique

cation exchange

General description

TSKgel® OApak-A columns are packed with porous hydrophilic polymer beads which have been chemically modified with a weak cation exchanger. They are optimized for the separation and analysis of organic acids by an ion-exclusion mechanism.This column is to be used in conjunction with the TSKgel OApak-P guard column which has a strong cation exchanger for the removal of dissociated strong acids under the isocratic eluent conditions of 0.75mM H2SO4. Applications include: organic acids in fruit juices, wine, beer, coffee, and salt solutions.

Recommended products

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

Legal Information

TSKgel is a registered trademark of Tosoh Corporation

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Protocols

Science Slam panel: Leading gene therapy developers discuss commercialization challenges and the importance of robust process development plans.

Science Slam panel: Leading gene therapy developers discuss commercialization challenges and the importance of robust process development plans.

Science Slam panel: Leading gene therapy developers discuss commercialization challenges and the importance of robust process development plans.

Science Slam panel: Leading gene therapy developers discuss commercialization challenges and the importance of robust process development plans.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service